iQure Pharma Targets Future with New Board Appointments
Life Sciences industry experts Michael D. Webb and Brian Cain bring extensive expertise in strategic pharmaceutical growth DELAWARE,...
top of page
News
Search
- Jun 22, 2020
iQure Pharma Inc. Announces Dr. Katrin Rupalla as the newest member of their Board of Directors
Delaware – June 2020, iQure Pharma Inc., a company dedicated to preclinical and early clinical development of Oncology and Central...
- Apr 16, 2020
iQure Pharma Inc. announces the Appointment of Professor Thomas Rades as CMC Advisor
Delaware – April 2020, iQure Pharma Inc., a company dedicated to preclinical and early clinical development of Oncology and Central...
- Nov 18, 2019
iQure Pharma Inc. announces the Appointment of Dr. Joseph Wettstein, as Chief Scientific Officer
Delaware – November 2019, iQure Pharma Inc., a company dedicated to preclinical and early development of oncology and CNS compounds,...
JPM Week
No Abuse
bottom of page